CD36 and metabolic dysfunction-associated steatotic liver disease: Among above fatty acid transporters, CD36 is the best characterized, which could promote fatty acid uptake in hepatocytes and thus enhance hepatic lipid accumulation in the progression of NAFLD [27,28].